We evaluated the diagnostic accuracy of fine-needle aspiration biopsy in a prospective study of 300 patients with previously undiagnosed bone lesions. Patients with suspected local recurrence of a primary bone tumour or a metastatic lesion of a previously diagnosed malignancy were excluded. Fine-needle aspiration biopsy was performed under radiological control as an outpatient procedure.
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We evaluated the diagnostic accuracy of fine-needle aspiration biopsy in a prospective study of 300 patients with previously undiagnosed bone lesions. Patients with suspected local recurrence of a primary bone tumour or a metastatic lesion of a previously diagnosed malignancy were excluded. Fine-needle aspiration biopsy was performed under radiological control as an outpatient procedure.
The series was grouped into three major categories: 1) benign bone lesions including infections; 2) primary malignant bone tumours; and 3) metastases including lymphomas and myelomas. We compared the cytological diagnosis with the final diagnosis as assessed by histological examination and/or the clinical and radiological features.
Material considered conclusive for cytological diagnosis was obtained from 251 of the 300 patients. Of the 49 failures, there were 24 aspirates with insufficient cellular yield and 25 in which a diagnosis could not be made although the cytological material was adequate in quantity. Most of the inconclusive aspirates (36/49) were obtained from benign bone lesions.
The diagnosis was correct in 239 (95%) of the 251 cases providing adequate cytological material. There were eight (3%) falsely benign diagnoses, one (0.3%) falsely malignant, and three cases in which we were unable to differentiate between sarcoma and a metastasis. Chondrosarcoma (2/12) gave the greatest diagnostic difficulty and Ewing's sarcoma the least (0/9). There were no decisive errors of treatment. All falsely benign or malignant diagnoses were questioned, and led to open biopsy since they did not correlate with the clinical and radiological features.
Our study suggests that fine-needle aspiration biopsy is a valid option for the diagnosis of bone tumours. It is a simple outpatient procedure which gives sufficient cytological material for the correct diagnosis in 80% of cases. As with histological analysis of material from open biopsy, the cytological assessment must agree with the clinical and radiological findings.
J Bone Joint Surg [Br] 1996; 78-B:258-63. Received 20 June 1995; Accepted 17 August 1995 Open biopsy is widely considered to be the procedure of choice for diagnostic tissue sampling of bone tumours. It has, however, some disadvantages (Mankin, Lange and Spanier 1982) . Not only is it an inpatient procedure, with associated costs, it often violates compartments and sometimes contaminates surrounding tissues. It is also associated with a risk of infection, haematoma and pathological fracture. As an alternative, the use of percutaneous biopsy of bone tumours to provide tissue for histological examination and for cytological analysis (Hajdu and Melamed 1971; Dollahite et al 1989) has been widely described (de Santos et al 1978; Moore et al 1979; Ayala and Zornosa 1983; Stoker and Kissin 1985) . Diagnosis of bone tumours based on fine-needle aspiration biopsy (Stormby and Å kerman 1973; Gatenby, Mulhern and Moldofsky 1984; Vetrani et al 1990) has so far not gained wide application, presumably because of anticipated difficulties in obtaining adequate tissue material (Hajdu and Melamed 1971; Tehranzadeh, Freiberger and Ghelman 1983) , partly due to technical problems (El-Khoury et al 1983) , but also to the morphological heterogeneity of bone tumours (Bhatia 1984) . Thus, it has been claimed that cytological samples obtained by fine-needle aspiration are often either unrepresentative (Enneking 1983; Fyfe, Henry and Mulholland 1983; Simon and Biermann 1993) or representative but still not diagnostic. Since clinical experience is limited it is not known to what extent these objections are valid.
We have used fine-needle aspiration biopsy for the routine diagnosis of bone tumours since the mid-1980s. We now report our experience of the cytological analysis of bone tumours with emphasis on diagnostic accuracy.
PATIENTS AND METHODS
Between 1987 and 1994 we studied 300 patients referred to our tumour service for diagnosis and treatment. All had been examined by plain radiography, CT and/or MRI before referral but none had previously had biopsy or surgery. Patients with a suspected local recurrence of a primary malignant bone tumour or a metastatic lesion of a previously diagnosed malignancy were excluded. There were 169 males and 131 females of median age 44 years (1 to 86). The most common tumour sites were the femur, pelvis, tibia, humerus and vertebra (Table I) .
We performed fine-needle aspiration biopsy (Cameco aspiration cytology pistol; Sebre Medical, Vellinge, Sweden; Althin needles; Medplast, Täby, Sweden) as an outpatient procedure at the first visit. Except for tumours with a large palpable mass, this was done under radiological control by the cytologist with the co-operation of the radiologist. The needle was inserted by the radiologist under local anaesthesia (Figs 1 to 3). Multiple aspirations in the area of interest were performed by the cytologist. The yield was immediately checked macroscopically and if necessary the aspiration was repeated.
In a trial study, a coaxial biopsy system with an eccentric CT-guided fine-needle biopsy of a lesion of the vertebral body of T8. drill was used to obtain cytological material in 12 patients with an intact cortex covering the lesion (Ahlström and Aström 1993) . The device consists of an outer cannula (diameter 2.2 mm) and a drill (diameter 2.0 mm) with an eccentric tip (Fig. 4 ) which makes a hole in the bone larger than the diameter of the cannula so that it is easy to advance the cannula by hand over the drill until it is anchored in the bone. This design facilitates penetration of cortical bone and provides a sufficiently large cortical opening to obtain multiple fine-needle aspirates from different sites. In 11 of these 12 cases there was sufficient conclusive material for cytology. Each aspirate was placed on to several slides, air-dried and fixed in neutral-buffered formalin. They were routinely stained with May-Grünwald-Giemsa. Additional slides were preserved for staining with immunohistochemical markers.
Our series was grouped into three major categories: 1) benign bone lesions including infections; 2) primary malignant bone tumours; and 3) metastases including lymphomas and myelomas. The cytological diagnosis was compared with the histological diagnosis after open biopsy and/or definitive surgery in 203 cases; in 75 fine-needle aspiration was followed by open biopsy. In 97 cases, there was no histological confirmation and the diagnosis was based on cytological analysis in combination with radiological and clinical features. In these 97 cases, there were ten patients with lymphoma and four with myeloma. Forty-four had a cytological diagnosis of metastasis and the definitive diagnosis was confirmed by identification of the primary malignancy. In another 33 patients, the clinical features, radiological appearance, and cytology all indicated a benign lesion (Table II) ; no surgical biopsy or treatment was performed. Finally, six sarcomas were diagnosed by cytology alone. Two of these patients had inoperable pelvic lesions (malignant fibrous histiocytoma) and in four chromosomal analysis of the aspirates revealed an 11:22 translocation which confirmed Ewing's sarcoma.
RESULTS
Material considered conclusive for cytological diagnosis was obtained in 251 of the 300 cases (Table III and Fig. 5 ). Of the 49 failures, there were 24 aspirates with insufficient cytological material; five were the result of failure to penetrate cortical bone. In the other 25 the cellular yield was adequate in amount but despite this a diagnosis could not be made. Inconclusive aspirates were most common in benign lesions.
A total of 113 lesions were cytologically assessed as benign. This was correct in 105 (93%); in the other eight, histological examination showed sarcoma in seven and malignant metastasis in one. Of 54 lesions cytologically diagnosed as osteosarcoma, 51 (94%) were confirmed; of the remaining three one was benign and two were metastases. Finally, 84 lesions were cytologically diagnosed as metastases; this was correct in 83 (99%). The sole exception proved to be a chordoma. Primary malignant tumours. Of the 67 lesions finally diagnosed as primary malignant bone tumours (Table IV) , the cellular yield was insufficient or inconclusive in eight. They required open biopsy to give the final diagnosis. Of the 59 remaining lesions, the cytological diagnosis was correct in 51; seven were erroneously assessed as benign and one as metastatic. Two proved to be chondrosarcoma, two osteosarcoma and one each of malignant fibrous histiocytoma, malignant haemangiopericytoma, chordoma and malignant giant-cell tumour.
From the point of view of treatment, there were almost no errors of diagnosis. In five of the eight misdiagnosed cases the cytological assessment was questioned as it did not agree with the clinical and radiological findings of malignancy. In four cases (two osteosarcomas, one chondrosarcoma, one haemangiopericytoma), open biopsy gave the final diagnosis and in one (malignant giant-cell tumour) the presence of lung metastases prompted re-evaluation of the diagnosis. The three remaining patients were treated without open biopsy by wide excision (malignant fibrous Diagram of the coaxial biopsy system (Ahlström and Å ström 1993). The eccentric drill makes a hole which has a diameter 0.2 mm larger than the drill. incorrectly diagnosed as malignant; this was an enchondroma classified as a low-grade chondrosarcoma. The patient had an open biopsy since clinical and radiological signs suggested that it was benign. The overall rate of correct cytological diagnosis was 80% (239/300) ( Table V) . Among the 251 cases providing adequate cytological material, the diagnosis was correct in 95% (239/251). The rate of falsely benign diagnoses was 3% (8/300) and of falsely malignant 0.3% (1/300).
DISCUSSION
Our study suggests that fine-needle aspiration biopsy is a valid option in the diagnosis of bone tumours. It is a simple outpatient procedure which offers sufficient tissue material for the correct diagnosis in 80% of bone tumours. As with open biopsy, however, the cytological assessment must agree with the clinical and radiological findings.
Our results are encouraging but fine-needle aspiration biopsy cannot completely replace open biopsy; one out of five lesions could not be diagnosed in this way. This is in agreement with the results of Dollahite et al (1989) who reported a diagnostic accuracy of 72% for bone sarcomas and 83% for giant-cell tumours, but a significantly lower rate for bone lesions thought to be benign.
In our study, the main reason for failure was inadequate sampling rather than diagnostic difficulties. In a comparative study of 69 bone tumours Agarwal and Wahal (1983) showed diagnostic agreement between cytology and histology in 83%. All failures were due to insufficient cytological material. Since such problems are easily recognised and indicate the need for open biopsy, the patients are not at increased risk of receiving inadequate treatment. Nonetheless, efforts should be made to improve the technique of obtaining adequate material.
In a trial with the coaxial biopsy system with an eccentric drill (Ahlström and Å ström 1993) sufficient cytological material was obtained in 11 of 12 cases. These patients had thick intact cortical bone over the lesions of interest, but they were easily reached. It is likely that use of this device will increase the rate of conclusive fine-needle aspirates from bone lesions. The needle can be guided in different directions once cortical bone has been penetrated and the device can easily be inserted at different sites in cortical bone without causing any major discomfort to the patient. This is important since it is well known that a bone tumour can vary considerably histologically and tissue must be obtained from different areas of the same lesion.
Of greater clinical importance than the technical failures were the cases which were misdiagnosed by cytological assessment of seemingly adequate fine-needle aspirates. In our series, there were eight falsely benign results and one falsely malignant. These misdiagnoses did not produce any errors of treatment but we would hesitate to rely entirely on fine-needle biopsy when high-dose chemotherapy or mutilating surgery such as amputation is being considered. We have, however, treated patients with Ewing's sarcoma and osteosarcoma without confirmation of the diagnosis with open biopsy.
We must emphasise that in this series we were concerned solely with the distinction between benign bone tumours, primary malignant bone tumours and metastases and did not consider specific histogenetic type and malignancy grade despite the fact that the cytological specimen was often diagnostic in these respects. A substantial number of cytological specimens were stained for immunohistochemistry which gives additional and/or confirmatory information. As regards treatment, it is very important to establish the correct histogenetic tumour type and grade for conditions which require preoperative chemotherapy such as osteosarcoma and Ewing's sarcoma. For most bone tumours, however, the distinction between benign bone tumours, primary malignant bone tumours, lymphomas, myelomas and metastatic lesions is sufficient for correct management.
As regards primary malignant bone tumours, our results imply that the greatest diagnostic difficulties are found with chondrosarcoma and the least with Ewing's sarcoma. In a cytological study of 14 cases of Ewing's sarcoma, Dahl, Akerman and Angervall (1986) concluded that the smears have a characteristic appearance and that fine-needle aspiration biopsy can be used for primary diagnosis and also for chromosomal analysis to reveal the typical 11:22 translocation of Ewing's sarcoma. Osteosarcoma seems to pose more cytodiagnostic difficulties than Ewing's sarcoma but less so than chondrosarcoma. Walaas and Kindblom (1990) logical specimens showed features suggestive of primary bone malignancy. The distinction, however, between chondroblastic osteosarcoma and high-grade chondrosarcoma and malignant fibrous histiocytoma proved to be difficult on smears. They suggested that resin-embedding of fineneedle aspirates gave additional light-microscopic information and also made the specimens suitable for electron microscopy. Immunohistochemistry was also of diagnostic value.
In the future, efforts should be focused on an improved biopsy technique to obtain a higher rate of conclusive cytological material. This can be done by an improved instrument design to facilitate multiple aspirates through cortical bone and also by wider application of CT (Settle et al 1990) . Improved diagnostic accuracy can be attained by the use of complementary methods such as electron microscopy and immunocytochemistry Kindblom 1990, 1991) . Objective methods such as DNA cytometry (Bodensteiner et al 1991) , proliferative rate assessments, karyotyping and molecular genetics may also be of value. These methods combined with increased clinical experience should reduce the need for open biopsy of bone tumours without jeopardising diagnostic safety.
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